New retinoblastoma ‐conjugated hyaluronic‐acid‐coated gold nanoparticles for intraocular treatment o...
New retinoblastoma ‐conjugated hyaluronic‐acid‐coated gold nanoparticles for intraocular treatment of chemoresistant RB
About this item
Full title
Author / Creator
Publisher
John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Intraocular drug delivery is a promising approach for treatment of ocular diseases. Chemotherapeutic drugs used in retinoblastoma (RB) treatment often lead to side effects and drug resistances. Therefore, new adjuvant therapies are needed to treat chemoresistant RBs. Biocompatible gold nanoparticles (GNPs) have unique antiangiogenic properties and...
Alternative Titles
Full title
New retinoblastoma ‐conjugated hyaluronic‐acid‐coated gold nanoparticles for intraocular treatment of chemoresistant RB
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A798121294
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A798121294
Other Identifiers
ISSN
1574-7891
DOI
10.1002/1878-0261.13587
